Financials in USD. Standardized financial statements.
A compact view of how Wellgistics Health, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue? | $23.34M | $18.13M | $0 | $32.78M |
| Revenue Growth? | +28.7% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $32.98M | $16.36M | $0 | $27.03M |
| Gross Profit? | -$9.64M | $1.77M | $0 | $5.75M |
| Gross Margin? | -41.3% | +9.7% | 0.0% | +17.5% |
| Operating Expenses? | $71.56M | $7.91M | $2.88M | $9.17M |
| Operating Income? | -$81.19M | -$6.15M | -$2.88M | -$3.42M |
| EBITDA? | -$77.98M | -$4.91M | -$2.88M | -$369,034 |
| Income Before Tax | -$101.27M | -$6.86M | -$2.90M | -$2.74M |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| Net Income? | -$101.27M | -$6.86M | -$2.90M | -$2.74M |
| EPS? | $-71.50 | $-6.50 | $-3.00 | $-2.90 |
| Diluted EPS? | $-71.50 | $-6.50 | $-3.00 | $-2.90 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality